Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. (Q50519141)
Jump to navigation
Jump to search
scientific article published in May 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. |
scientific article published in May 1999 |
Statements
1 reference
Inhibitors of V-type ATPases, bafilomycin A1 and concanamycin A, protect against beta-amyloid-mediated effects on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. (English)
1 reference
M D Kane
1 reference
R D Schwarz
1 reference
L St Pierre
1 reference
M D Watson
1 reference
M R Emmerling
1 reference
P A Boxer
1 reference
G K Walker
1 reference
1 May 1999
1 reference
72
1 reference
5
1 reference
1939-1947
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference